Notices. DEPARTMENT OF JUSTICE
248 words·~1 min read·
/register/2001/12/21/01-31408A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-11-M DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 8, 2001, American Radiolabeled Chemical, Inc., 11624 Bowling Green Drive, St. Louis, Missouri 63146, made application by renewal and by letter dated May 2, 2001, to the Drug Enforcement Administration
(DEA)for registration as a bulk manufacturer of the basic classes of controlled substances listed below: Drug Schedule Gamma hydroxybutyric acid
(2010)I Lysergic acid diethylamide
(7315)I Dimethyltryptamine
(7435)I Dihydromophine
(9145)I Phencyclidine
(7471)II Cocaine
(9041)II Codeine
(9050)II Hydromorphone
(9150)II Oxycodone
(9143)II Thebaine
(9333)II Benzoylecgonine
(9180)II Meperidine
(9230)II Metazocine
(9240)II Morphine
(9300)II Oxymorphone
(9652)II The firm plans to bulk manufacture small quantities of the listed controlled substances as radiolabeled compounds. Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than February 19, 2002. Dated: November 15, 2001. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 01-31408 Filed 12-20-01; 8:45 am]